Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Aug 16, 2024

SELL
$65.94 - $99.04 $791 - $1,188
-12 Closed
0 $0
Q4 2022

Aug 16, 2024

BUY
$30.35 - $53.15 $364 - $637
12 New
12 $594,000
Q4 2021

Aug 16, 2024

SELL
$72.5 - $100.68 $507 - $704
-7 Closed
0 $0
Q3 2021

Aug 16, 2024

BUY
$90.24 - $124.05 $631 - $868
7 New
7 $668,000
Q1 2021

Aug 16, 2024

SELL
$116.57 - $155.01 $466 - $620
-4 Reduced 36.36%
7 $922,000
Q2 2020

Aug 16, 2024

BUY
$55.75 - $92.75 $390 - $649
7 Added 175.0%
11 $956,000
Q1 2020

Aug 16, 2024

SELL
$37.9 - $104.44 $454 - $1,253
-12 Reduced 75.0%
4 $232,000
Q4 2019

Aug 16, 2024

BUY
$77.66 - $99.74 $1,242 - $1,595
16 New
16 $1.48 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.33B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.